Therefore, it is recommended that some potential early biomarkers for AKI also be examined in the future studies (e.g., interleukin-18, kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin). The gene discussed is HAVCR1; the disease is acute kidney injury.